Traditionally, breast cancer is divided into four different subtypes according to the positivity or negativity of hormone receptor (HR) and human epidermal growth factor 2 (HER2), namely, HR+/HER2-, HR+/HER2+, HR-/HER2+, and HR-/HER2-. This evidence concerns the gene ERBB2 and breast carcinoma.